Published in Immunology on October 01, 1989
Theileria annulata induces abberrant T cell activation in vitro and in vivo. Clin Exp Immunol (1995) 0.87
Development and characterization of a monoclonal antibody specific for the bovine low-affinity interleukin-2 receptor, BoCD25. Immunology (1992) 0.81
T cell growth factor: parameters of production and a quantitative microassay for activity. J Immunol (1978) 28.92
T cell growth factor receptors. Quantitation, specificity, and biological relevance. J Exp Med (1981) 10.66
A monoclonal antibody that appears to recognize the receptor for human T-cell growth factor; partial characterization of the receptor. Nature (1982) 9.42
Continuous proliferation of murine antigen-specific helper T lymphocytes in culture. J Exp Med (1979) 7.20
Structure and expression of a cloned cDNA for human interleukin-2. Nature (1983) 7.04
Low and high affinity cellular receptors for interleukin 2. Implications for the level of Tac antigen. J Exp Med (1984) 6.45
Transient expression of interleukin 2 receptors. Consequences for T cell growth. J Exp Med (1983) 5.82
Molecular cloning of cDNA encoding human interleukin-2 receptor. Nature (1984) 4.95
Demonstration of a non-Tac peptide that binds interleukin 2: a potential participant in a multichain interleukin 2 receptor complex. Proc Natl Acad Sci U S A (1986) 4.61
A graphic method for the determination and presentation of binding parameters in a complex system. Anal Biochem (1967) 4.32
Novel interleukin-2 receptor subunit detected by cross-linking under high-affinity conditions. Science (1986) 4.30
The interleukin 2 receptor. Functional consequences of its bimolecular structure. J Exp Med (1987) 3.66
Direct demonstration of the identity of T cell growth factor binding protein and the Tac antigen. J Exp Med (1983) 2.82
Characterization of the human receptor for T-cell growth factor. Proc Natl Acad Sci U S A (1983) 2.76
High-affinity receptor-mediated internalization and degradation of interleukin 2 in human T cells. J Exp Med (1986) 2.37
Internalization of interleukin 2 is mediated by the beta chain of the high-affinity interleukin 2 receptor. J Exp Med (1987) 2.15
Unique structure of murine interleukin-2 as deduced from cloned cDNAs. Nature (1985) 2.15
Only high-affinity receptors for interleukin 2 mediate internalization of ligand. Proc Natl Acad Sci U S A (1986) 2.12
Nucleotide sequence and expression of a mouse interleukin 2 receptor cDNA. J Immunol (1985) 2.00
Contribution of a p75 interleukin 2 binding peptide to a high-affinity interleukin 2 receptor complex. Proc Natl Acad Sci U S A (1987) 1.57
Contrasting interleukin 2 binding properties of the alpha (p55) and beta (p70) protein subunits of the human high-affinity interleukin 2 receptor. J Exp Med (1987) 1.57
The murine interleukin 2 receptor. Irreversible cross-linking of radiolabeled interleukin 2 to high affinity interleukin 2 receptors reveals a noncovalently associated subunit. J Immunol (1987) 1.29
Molecular cloning of a functional bovine interleukin 2 cDNA. Proc Natl Acad Sci U S A (1986) 1.29
Retention of biological activity following radioiodination of human interleukin 2: comparison with biosynthetically labeled growth factor in receptor binding assays. J Immunol Methods (1985) 1.27
The human receptor for T-cell growth factor. Evidence for variable post-translational processing, phosphorylation, sulfation, and the ability of precursor forms of the receptor to bind T-cell growth factor. J Biol Chem (1985) 1.20
Structure-function relationships for the IL 2-receptor system. I. Localization of a receptor binding site on IL 2. J Immunol (1986) 1.11
Cloning, sequence, and expression of bovine interleukin 2. Proc Natl Acad Sci U S A (1986) 1.10
Cloning of cDNA for the bovine IL-2 receptor (bovine Tac antigen). Immunology (1988) 1.02
Structure-function relationships for the IL 2-receptor system. II. Localization of an IL 2 binding site on high and low affinity receptors. J Immunol (1986) 1.02
Production and characterization of bovine interleukin-2. Immunology (1984) 0.92
Evidence for two discrete phases of IL-2 production in bovine lymphocytes. J Immunol (1988) 0.82
Genome cross-referencing and XREFdb: implications for the identification and analysis of genes mutated in human disease. Nat Genet (1997) 10.14
Intrinsically disordered protein. J Mol Graph Model (2001) 8.54
Expression of recombinant plasmids in mammalian cells is enhanced by sodium butyrate. Nucleic Acids Res (1983) 5.61
High-mobility-group chromosomal proteins: architectural components that facilitate chromatin function. Prog Nucleic Acid Res Mol Biol (1996) 4.22
Sodium butyrate inhibits histone deacetylation in cultured cells. Cell (1978) 4.20
The solution structure of an HMG-I(Y)-DNA complex defines a new architectural minor groove binding motif. Nat Struct Biol (1997) 2.56
Transcriptionally active chromatin. Biochim Biophys Acta (1984) 2.39
Comparative genomics, genome cross-referencing and XREFdb. Trends Genet (1995) 2.35
Complete murine cDNA sequence, genomic structure, and tissue expression of the high mobility group protein HMG-I(Y). J Biol Chem (1988) 2.30
Intravascular extraction of problematic or infected permanent pacemaker leads: 1994-1996. U.S. Extraction Database, MED Institute. Pacing Clin Electrophysiol (1999) 2.24
Minichromosome assembly of non-integrated plasmid DNA transfected into mammalian cells. Nucleic Acids Res (1985) 2.20
Alternative processing of mRNAs encoding mammalian chromosomal high-mobility-group proteins HMG-I and HMG-Y. Mol Cell Biol (1989) 2.07
The influence of DNA and nucleosome structure on integration events directed by HIV integrase. J Biol Chem (1994) 2.03
Pim-1: a serine/threonine kinase with a role in cell survival, proliferation, differentiation and tumorigenesis. J Vet Sci (2001) 1.89
Pim kinase-dependent inhibition of c-Myc degradation. Oncogene (2008) 1.85
Multiple closely-linked NFAT/octamer and HMG I(Y) binding sites are part of the interleukin-4 promoter. Nucleic Acids Res (1993) 1.80
Evidence for a shared structural role for HMG1 and linker histones B4 and H1 in organizing chromatin. EMBO J (1996) 1.78
Posttranscriptional gene regulation and specific binding of the nonhistone protein HMG-I by the 3' untranslated region of bovine interleukin 2 cDNA. Proc Natl Acad Sci U S A (1987) 1.77
HMG protein family members stimulate human immunodeficiency virus type 1 and avian sarcoma virus concerted DNA integration in vitro. J Virol (1999) 1.71
Limb-girdle muscular dystrophy type 2G is caused by mutations in the gene encoding the sarcomeric protein telethonin. Nat Genet (2000) 1.71
Headache in mild-to-moderate hypertension and its reduction by irbesartan therapy. Arch Intern Med (2000) 1.68
Conserved chromosomal positions of dual domains of the ets protooncogene in cats, mice, and humans. Proc Natl Acad Sci U S A (1986) 1.67
The DNA-bending protein HMG-1 enhances progesterone receptor binding to its target DNA sequences. Mol Cell Biol (1994) 1.65
Organization, inducible-expression and chromosome localization of the human HMG-I(Y) nonhistone protein gene. Nucleic Acids Res (1993) 1.61
A poly(dA-dT) upstream activating sequence binds high-mobility group I protein and contributes to lymphotoxin (tumor necrosis factor-beta) gene regulation. Mol Cell Biol (1992) 1.61
Gene elav of Drosophila melanogaster: a prototype for neuronal-specific RNA binding protein gene family that is conserved in flies and humans. J Neurobiol (1993) 1.57
Impact of age and gender on blood pressure and low-density lipoprotein cholesterol reduction: results of a pooled analysis. Curr Med Res Opin (2012) 1.39
Phosphorylation by cdc2 kinase modulates DNA binding activity of high mobility group I nonhistone chromatin protein. J Biol Chem (1991) 1.39
High mobility group protein I(Y) is required for function and for c-Rel binding to CD28 response elements within the GM-CSF and IL-2 promoters. Immunity (1996) 1.37
High-mobility group protein HMG-I localizes to G/Q- and C-bands of human and mouse chromosomes. J Cell Biol (1989) 1.36
Pim-1 protein expression is regulated by its 5'-untranslated region and translation initiation factor elF-4E. Cell Growth Differ (1997) 1.29
Molecular cloning of a functional bovine interleukin 2 cDNA. Proc Natl Acad Sci U S A (1986) 1.29
Purification and postsynthetic modifications of Friend erythroleukemic cell high mobility group protein HMG-I. Anal Biochem (1986) 1.25
Butyrate suppression of position-effect variegation in Drosophila melanogaster. Mol Gen Genet (1980) 1.21
Sodium butyrate stimulates DNA repair in UV-irradiated normal and xeroderma pigmentosum human fibroblasts. J Biol Chem (1982) 1.20
Changes in superhelicity are introduced into closed circular DNA by binding of high mobility group protein I/Y. J Biol Chem (1995) 1.19
Specific A . T DNA sequence binding of RP-HPLC purified HMG-I. Biochem Biophys Res Commun (1987) 1.19
FR900482 class of anti-tumor drugs cross-links oncoprotein HMG I/Y to DNA in vivo. Chem Biol (2000) 1.16
PIM1 phosphorylates and negatively regulates ASK1-mediated apoptosis. Oncogene (2009) 1.15
Sodium butyrate induces new gene expression in Friend erythroleukemic cells. J Biol Chem (1979) 1.14
Expression of mRNAs encoding mammalian chromosomal proteins HMG-I and HMG-Y during cellular proliferation. Exp Cell Res (1990) 1.13
Elevated high mobility group-I(Y) gene expression is associated with progressive transformation of mouse mammary epithelial cells. Cancer Res (1993) 1.12
Chromatin remodeling of the interleukin-2 gene: distinct alterations in the proximal versus distal enhancer regions. Nucleic Acids Res (1998) 1.12
Competition between HMG-I(Y), HMG-1 and histone H1 on four-way junction DNA. Nucleic Acids Res (1997) 1.10
Mechanisms regulating transient expression of mammalian cytokine genes and cellular oncogenes. Prog Nucleic Acid Res Mol Biol (1990) 1.07
A conformational study of the sequence specific binding of HMG-I (Y) with the bovine interleukin-2 cDNA. Biochem Int (1988) 1.07
Recombinant human pim-1 protein exhibits serine/threonine kinase activity. J Biol Chem (1991) 1.06
The role of high-mobility group I(Y) proteins in expression of IL-2 and T cell proliferation. J Immunol (2000) 1.05
Ribosomal genes of Xenopus laevis: evidence of nucleosomes in transcriptionally active chromatin. Science (1976) 1.04
Genomic transcriptional activity and the structure of chromatin. Nature (1976) 1.04
A region of mouse chromosome 16 is syntenic to the DiGeorge, velocardiofacial syndrome minimal critical region. Genome Res (1997) 1.03
Cloning of cDNA for the bovine IL-2 receptor (bovine Tac antigen). Immunology (1988) 1.02
Human X inactivation center induces random X chromosome inactivation in male transgenic mice. Genomics (1999) 1.01
Stability changes in pim-1 proto-oncogene mRNA after mitogen stimulation of normal lymphocytes. J Immunol (1991) 1.00
Inhibition of T-lymphocyte mitogenic responses and effects on cell functions by bovine herpesvirus 1. J Virol (1989) 0.99
Defective thymocyte maturation in horses with severe combined immunodeficiency. J Immunol (1987) 0.99
Hoechst 33258, distamycin A, and high mobility group protein I (HMG-I) compete for binding to mouse satellite DNA. Chromosoma (1992) 0.98
Directional binding of HMG-I(Y) on four-way junction DNA and the molecular basis for competitive binding with HMG-1 and histone H1. Nucleic Acids Res (1999) 0.98
Differential in vivo modifications of the HMGI(Y) nonhistone chromatin proteins modulate nucleosome and DNA interactions. Biochemistry (2000) 0.97
Persistent infection of rabbits with bovine leukemia virus associated with development of immune dysfunction. J Virol (1989) 0.97
www.elearnSCI.org: a global educational initiative of ISCoS. Spinal Cord (2013) 0.96
Carbohydrate modifications of the high mobility group proteins. Proc Natl Acad Sci U S A (1981) 0.96
Structure of Xenopus ribosomal gene chromatin during changes in genomic transcription rates. Cold Spring Harb Symp Quant Biol (1978) 0.96
pim-1 proto-oncogene expression in anti-CD3-mediated T cell activation is associated with protein kinase C activation and is independent of Raf-1. J Immunol (1996) 0.96
Pim-1 negatively regulates the activity of PTP-U2S phosphatase and influences terminal differentiation and apoptosis of monoblastoid leukemia cells. Arch Biochem Biophys (2001) 0.95
Sequence and analysis of the murine Hmgiy (Hmga1) gene locus. Gene (2001) 0.95
High mobility group-I(Y) protein facilitates nuclear factor-kappaB binding and transactivation of the inducible nitric-oxide synthase promoter/enhancer. J Biol Chem (1999) 0.95
Nucleosome structure of Xenopus oocyte amplified ribosomal genes. Biochemistry (1978) 0.94
NMR studies of sodium and potassium in various biological tissues. Ann N Y Acad Sci (1973) 0.94
Base-pair substitutions in avian sarcoma virus U5 and U3 long terminal repeat sequences alter the process of DNA integration in vitro. J Virol (2001) 0.94
High-mobility-group protein I can modulate binding of transcription factors to the U5 region of the human immunodeficiency virus type 1 proviral promoter. J Virol (2000) 0.93
Production and characterization of biologically active human GM-CSF secreted by genetically modified plant cells. Protein Expr Purif (2000) 0.93
Xrep, a plasmid-stimulating X chromosomal sequence bearing similarities to the BK virus replication origin and viral enhancers. Nucleic Acids Res (1986) 0.92
HMGI(Y) activation by chromosome 6p21 rearrangements in multilineage mesenchymal cells from pulmonary hamartoma. Am J Pathol (1997) 0.91
Microheterogeneity of the mammalian high mobility group (HMG) proteins 1 and 2 investigated by reverse-phase high performance liquid chromatography. Anal Biochem (1985) 0.91
Silencer activity in the interferon-A gene promoters. J Biol Chem (1997) 0.91
Characterization of the testes-specific pim-1 transcript in rat. Nucleic Acids Res (1992) 0.90
Composition of a polysaccharide from mycoplasma (F-38) recognised by antibodies from goats with contagious pleuropneumonia. Res Vet Sci (1987) 0.90
Induction of high mobility group-I(Y) protein by endotoxin and interleukin-1beta in vascular smooth muscle cells. Role in activation of inducible nitric oxide synthase. J Biol Chem (1999) 0.90
Large granular lymphocytes from SCID horses develop potent cytotoxic activity after treatment with human recombinant interleukin 2. J Immunol (1987) 0.90
Recombination of exogenous interleukin 2 receptor gene flanked by immunoglobulin recombination signal sequences in a pre-B cell line and transgenic mice. J Biol Chem (1991) 0.89
The non-histone chromosomal protein HMG-I(Y) contributes to repression of the immunoglobulin heavy chain germ-line epsilon RNA promoter. Eur J Immunol (1995) 0.89
A nuclear magnetic resonance study of sodium ion interaction with erythrocyte membranes. Biochem Biophys Res Commun (1970) 0.89
Expression and characterization of the interleukin 2 receptor in Theileria parva-infected bovine lymphocytes. Eur J Immunol (1989) 0.89
Microheterogeneity of the mammalian high-mobility group proteins 14 and 17 investigated by reverse-phase high-performance liquid chromatography. Anal Biochem (1985) 0.88
Molecular homogeneity of heat-stable enterotoxins produced by bovine enterotoxigenic Escherichia coli. Infect Immun (1984) 0.88
Tumor promoter induces high mobility group HMG-Y protein expression in transformation-sensitive but not -resistant cells. Oncogene (1998) 0.88
Letter: 23Na interaction with bacterial surfaces: a comment on nuclear magnetic resonance invisible signals. Biophys J (1973) 0.88